SOMCL-863 is a selective and orally bioavailable c-Met inhibitor that exhibits antitumor activity both in vitro and in vivo. References: Wang L, Ai J, Shen Y, Zhang H, Peng X, Huang M, Zhang A, Ding J, Geng M. SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo. Cancer Lett. 2014 Aug 28;351(1):143-50. doi: 10.1016/j.canlet.2014.05.012. Epub 2014 May 28. PubMed PMID: 24880078.

纯度：≥98%

CAS：1452310-87-0